 | • レポートコード：QYR9ST13635 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、多発性骨髄腫診断の世界市場について調査・分析し、多発性骨髄腫診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（多発性骨髄腫抑制、多発性骨髄腫治療）、用途別（機関販売、病院薬局、専門クリニック、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多発性骨髄腫診断市場動向 ・主要企業別マーケットシェア ・多発性骨髄腫診断の種類別市場規模2014-2019 （多発性骨髄腫抑制、多発性骨髄腫治療） ・多発性骨髄腫診断の用途別市場規模2014-2019 （機関販売、病院薬局、専門クリニック、ドラッグストア） ・多発性骨髄腫診断の北米市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫診断のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫診断の中国市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫診断の日本国内市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫診断の東南アジア市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫診断のインド市場：主要企業・種類別/用途別市場規模 ・多発性骨髄腫診断の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb Company、F. Hoffmann-La Roche Ltd、Genzyme Corporation、Celgene Corporation、Millennium Pharmaceuticals、Novartis AG、Amgen, Inc、Juno Therapeutics、Janssen Biotech, Inc、Johnson & Johnson、GlaxoSmithKline plc、Pfizer、AbbVie Inc、Innate Pharma SA、Onyx Pharmaceuticals、Celldex Therapeutics, Inc、Takeda Pharmaceuticals） ・多発性骨髄腫診断の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Plasma cells help in fighting infection however, malignant plasma cells in multiple myeloma accumulate in the bone marrow, blocks the normal function of plasma cells. The M protein which is an abnormal antibody produced by malignant plasma cells cause tumors, bone destruction, kidney damage, and damaged immune function. However, in the recent years, ten new drugs have received in approval in short period of time due to the formation of Multiple Myeloma Research Foundation and the increasing attention, advancement, and researches for multiple myeloma diagnostics and therapies.
In 2018, the global Multiple Myeloma Diagnostic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Multiple Myeloma Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Myeloma Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd
Genzyme Corporation
Celgene Corporation
Millennium Pharmaceuticals
Novartis AG
Amgen, Inc
Juno Therapeutics
Janssen Biotech, Inc
Johnson & Johnson
GlaxoSmithKline plc
Pfizer
AbbVie Inc
Innate Pharma SA
Onyx Pharmaceuticals
Celldex Therapeutics, Inc
Takeda Pharmaceuticals
Market segment by Type, the product can be split into
Multiple Myeloma Suppression
Multiple Myeloma Treatment
Market segment by Application, split into
Institutional Sales
Hospital Pharmacies
Specialty Clinic
Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Multiple Myeloma Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Multiple Myeloma Diagnostic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Multiple Myeloma Diagnostic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Multiple Myeloma Diagnostic Market Size Growth Rate by Type (2014-2025)
1.4.2 Multiple Myeloma Suppression
1.4.3 Multiple Myeloma Treatment
1.5 Market by Application
1.5.1 Global Multiple Myeloma Diagnostic Market Share by Application (2019-2025)
1.5.2 Institutional Sales
1.5.3 Hospital Pharmacies
1.5.4 Specialty Clinic
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Multiple Myeloma Diagnostic Market Size
2.2 Multiple Myeloma Diagnostic Growth Trends by Regions
2.2.1 Multiple Myeloma Diagnostic Market Size by Regions (2019-2025)
2.2.2 Multiple Myeloma Diagnostic Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Multiple Myeloma Diagnostic Market Size by by Players
3.1.1 Global Multiple Myeloma Diagnostic Revenue by by Players (2014-2019)
3.1.2 Global Multiple Myeloma Diagnostic Revenue Market Share by by Players (2014-2019)
3.1.3 Global Multiple Myeloma Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2 Multiple Myeloma Diagnostic Key Players Head office and Area Served
3.3 Key Players Multiple Myeloma Diagnostic Product/Solution/Service
3.4 Date of Enter into Multiple Myeloma Diagnostic Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Multiple Myeloma Diagnostic Market Size by Type (2014-2019)
4.2 Global Multiple Myeloma Diagnostic Market Size by Application (2014-2019)
5 North America
5.1 North America Multiple Myeloma Diagnostic Market Size (2014-2019)
5.2 Multiple Myeloma Diagnostic Key Players in North America
5.3 North America Multiple Myeloma Diagnostic Market Size by Type
5.4 North America Multiple Myeloma Diagnostic Market Size by Application
6 Europe
6.1 Europe Multiple Myeloma Diagnostic Market Size (2014-2019)
6.2 Multiple Myeloma Diagnostic Key Players in Europe
6.3 Europe Multiple Myeloma Diagnostic Market Size by Type
6.4 Europe Multiple Myeloma Diagnostic Market Size by Application
7 China
7.1 China Multiple Myeloma Diagnostic Market Size (2014-2019)
7.2 Multiple Myeloma Diagnostic Key Players in China
7.3 China Multiple Myeloma Diagnostic Market Size by Type
7.4 China Multiple Myeloma Diagnostic Market Size by Application
8 Japan
8.1 Japan Multiple Myeloma Diagnostic Market Size (2014-2019)
8.2 Multiple Myeloma Diagnostic Key Players in Japan
8.3 Japan Multiple Myeloma Diagnostic Market Size by Type
8.4 Japan Multiple Myeloma Diagnostic Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Multiple Myeloma Diagnostic Market Size (2014-2019)
9.2 Multiple Myeloma Diagnostic Key Players in Southeast Asia
9.3 Southeast Asia Multiple Myeloma Diagnostic Market Size by Type
9.4 Southeast Asia Multiple Myeloma Diagnostic Market Size by Application
10 India
10.1 India Multiple Myeloma Diagnostic Market Size (2014-2019)
10.2 Multiple Myeloma Diagnostic Key Players in India
10.3 India Multiple Myeloma Diagnostic Market Size by Type
10.4 India Multiple Myeloma Diagnostic Market Size by Application
11 Central & South America
11.1 Central & South America Multiple Myeloma Diagnostic Market Size (2014-2019)
11.2 Multiple Myeloma Diagnostic Key Players in Central & South America
11.3 Central & South America Multiple Myeloma Diagnostic Market Size by Type
11.4 Central & South America Multiple Myeloma Diagnostic Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb Company
12.1.1 Bristol-Myers Squibb Company Company Details
12.1.2 Company Description and Business Overview
12.1.3 Multiple Myeloma Diagnostic Introduction
12.1.4 Bristol-Myers Squibb Company Revenue in Multiple Myeloma Diagnostic Business (2014-2019))
12.1.5 Bristol-Myers Squibb Company Recent Development
12.2 F. Hoffmann-La Roche Ltd
12.2.1 F. Hoffmann-La Roche Ltd Company Details
12.2.2 Company Description and Business Overview
12.2.3 Multiple Myeloma Diagnostic Introduction
12.2.4 F. Hoffmann-La Roche Ltd Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Ltd Recent Development
12.3 Genzyme Corporation
12.3.1 Genzyme Corporation Company Details
12.3.2 Company Description and Business Overview
12.3.3 Multiple Myeloma Diagnostic Introduction
12.3.4 Genzyme Corporation Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.3.5 Genzyme Corporation Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Multiple Myeloma Diagnostic Introduction
12.4.4 Celgene Corporation Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.4.5 Celgene Corporation Recent Development
12.5 Millennium Pharmaceuticals
12.5.1 Millennium Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Multiple Myeloma Diagnostic Introduction
12.5.4 Millennium Pharmaceuticals Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.5.5 Millennium Pharmaceuticals Recent Development
12.6 Novartis AG
12.6.1 Novartis AG Company Details
12.6.2 Company Description and Business Overview
12.6.3 Multiple Myeloma Diagnostic Introduction
12.6.4 Novartis AG Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.6.5 Novartis AG Recent Development
12.7 Amgen, Inc
12.7.1 Amgen, Inc Company Details
12.7.2 Company Description and Business Overview
12.7.3 Multiple Myeloma Diagnostic Introduction
12.7.4 Amgen, Inc Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.7.5 Amgen, Inc Recent Development
12.8 Juno Therapeutics
12.8.1 Juno Therapeutics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Multiple Myeloma Diagnostic Introduction
12.8.4 Juno Therapeutics Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.8.5 Juno Therapeutics Recent Development
12.9 Janssen Biotech, Inc
12.9.1 Janssen Biotech, Inc Company Details
12.9.2 Company Description and Business Overview
12.9.3 Multiple Myeloma Diagnostic Introduction
12.9.4 Janssen Biotech, Inc Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.9.5 Janssen Biotech, Inc Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Details
12.10.2 Company Description and Business Overview
12.10.3 Multiple Myeloma Diagnostic Introduction
12.10.4 Johnson & Johnson Revenue in Multiple Myeloma Diagnostic Business (2014-2019)
12.10.5 Johnson & Johnson Recent Development
12.11 GlaxoSmithKline plc
12.12 Pfizer
12.13 AbbVie Inc
12.14 Innate Pharma SA
12.15 Onyx Pharmaceuticals
12.16 Celldex Therapeutics, Inc
12.17 Takeda Pharmaceuticals
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Multiple Myeloma Diagnostic Key Market Segments
Table Key Players Multiple Myeloma Diagnostic Covered
Table Global Multiple Myeloma Diagnostic Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Multiple Myeloma Suppression Figures
Table Key Players of Multiple Myeloma Suppression
Figuer Multiple Myeloma Treatment Figures
Table Key Players of Multiple Myeloma Treatment
Table Global Multiple Myeloma Diagnostic Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Multiple Myeloma Diagnostic Market Share by Application in 2018 & 2025
Figure Institutional Sales Case Studies
Figure Hospital Pharmacies Case Studies
Figure Specialty Clinic Case Studies
Figure Drug Stores Case Studies
Figure Multiple Myeloma Diagnostic Report Years Considered
Figure Global Multiple Myeloma Diagnostic Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Multiple Myeloma Diagnostic Market Size by Regions 2019-2025 (Million US$)
Table Global Multiple Myeloma Diagnostic Market Size by Regions 2019-2025 (Million US$)
Table Global Multiple Myeloma Diagnostic Market Share by Regions 2014-2019
Figure Global Multiple Myeloma Diagnostic Market Share by Regions 2014-2019
Figure Global Multiple Myeloma Diagnostic Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Multiple Myeloma Diagnostic Revenue by by Players (2014-2019) (Million US$)
Table Global Multiple Myeloma Diagnostic Market Share by by Players (2014-2019)
Figure Global Multiple Myeloma Diagnostic Market Share by by Players in 2018
Table Global Multiple Myeloma Diagnostic by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Multiple Myeloma Diagnostic Product/Solution/Service
Table Date of Enter into Multiple Myeloma Diagnostic Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Multiple Myeloma Diagnostic Market Size by Type (2014-2019) (Million US$)
Table Global Multiple Myeloma Diagnostic Market Size Share by Type (2014-2019)
Figure Global Multiple Myeloma Diagnostic Market Size Market Share by Type (2014-2019)
Table Global Multiple Myeloma Diagnostic Market Size by Application (2014-2019) (Million US$)
Table Global Multiple Myeloma Diagnostic Market Size Share by Application (2014-2019)
Figure Global Multiple Myeloma Diagnostic Market Size Market Share by Application (2014-2019)
Figure Global Multiple Myeloma Diagnostic Revenue Market Share by Application in 2018
Figure North America Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table North America Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table North America Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table North America Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table North America Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table North America Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table North America Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Figure Europe Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table Europe Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table Europe Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table Europe Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table Europe Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table Europe Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table Europe Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Figure China Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table China Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table China Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table China Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table China Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table China Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table China Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Figure Japan Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table Japan Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table Japan Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table Japan Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table Japan Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table Japan Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table Japan Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Figure Southeast Asia Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table Southeast Asia Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table Southeast Asia Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Figure India Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table India Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table India Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table India Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table India Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table India Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table India Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Figure Central & South America Multiple Myeloma Diagnostic Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Multiple Myeloma Diagnostic Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Multiple Myeloma Diagnostic Market Share (2018-2019)
Table Central & South America Multiple Myeloma Diagnostic Market Size by Type 2014-2019 (Million US$)
Table Central & South America Multiple Myeloma Diagnostic Market Share by Type 2014-2019
Table Central & South America Multiple Myeloma Diagnostic Market Size by Application 2014-2019 (Million US$)
Table Central & South America Multiple Myeloma Diagnostic Market Share by Application 2014-2019
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table F. Hoffmann-La Roche Ltd Company Details
Table F. Hoffmann-La Roche Ltd Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table F. Hoffmann-La Roche Ltd Recent Development
Table Genzyme Corporation Company Details
Table Genzyme Corporation Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Genzyme Corporation Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Genzyme Corporation Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Celgene Corporation Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Celgene Corporation Recent Development
Table Millennium Pharmaceuticals Company Details
Table Millennium Pharmaceuticals Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Millennium Pharmaceuticals Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Novartis AG Recent Development
Table Amgen, Inc Company Details
Table Amgen, Inc Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Amgen, Inc Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Amgen, Inc Recent Development
Table Juno Therapeutics Company Details
Table Juno Therapeutics Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Juno Therapeutics Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Juno Therapeutics Recent Development
Table Janssen Biotech, Inc Company Details
Table Janssen Biotech, Inc Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Janssen Biotech, Inc Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Janssen Biotech, Inc Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Multiple Myeloma Diagnostic Business 2014-2019 (Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Multiple Myeloma Diagnostic Business (2014-2019)
Table Johnson & Johnson Recent Development
Table GlaxoSmithKline plc Company Details
Table Pfizer Company Details
Table AbbVie Inc Company Details
Table Innate Pharma SA Company Details
Table Onyx Pharmaceuticals Company Details
Table Celldex Therapeutics, Inc Company Details
Table Takeda Pharmaceuticals Company Details
Table Global Multiple Myeloma Diagnostic Market Size by Regions (Million US$) 2019-2025
Figure Global Multiple Myeloma Diagnostic Market Size Share by Regions (2019-2025)
Figure Global Multiple Myeloma Diagnostic Market Size Share by Regions in 2025
Figure North America Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Figure Europe Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Figure China Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Figure Japan Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Figure India Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Multiple Myeloma Diagnostic Market Size Forecast (2019-2025)(Million USD)
Table Global Multiple Myeloma Diagnostic Market Size by Product (2019-2025) (Million US$)
Figure Global Multiple Myeloma Diagnostic Market Size by Product (2019-2025)
Figure Global Multiple Myeloma Diagnostic Market Size by Product in 2025
Table Global Multiple Myeloma Diagnostic Market Size by Application (2019-2025) (Million US$)
Figure Global Multiple Myeloma Diagnostic Market Size by Application (2019-2025)
Figure Global Multiple Myeloma Diagnostic Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
多発性骨髄腫用るCAR T細胞療法の世界市場：市場規模・現状・予測 CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…- 多発性骨髄腫治療の世界市場：市場規模・現状・予測 Multiple Myeloma (MM) is a haematological malignancy considered by the propagation of plasma cells in the bone marrow. The disease is incurable; though over the few years there have been substantial developments in therapy, determined by a greater understanding of pathophysiology. Multiple myeloma i…
- 多発性硬化症治療の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and somet…
- 多発性硬化症薬の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the s…
- 多発性硬化症の世界市場：市場規模・現状・予測 Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentia…